Results
Your Objectives.
Our Scoreboard.
A lot of firms measure success by activity. Media hits. Impressions. Meetings taken. We don't. Your objectives are the only ones that matter. Every strategy we deploy, every resource we activate is measured against one thing: did it move you closer to the outcome you needed?
Results in this world aren't always a vote count or a stock price. Sometimes it's a conversation that shifted. An opponent that lost momentum. A program that's still running two decades later because it was built to last.
We define objectives at the start of every engagement and revisit them as the landscape evolves. Not because it's good process. Because it's the only way to know whether what you're doing is actually working.
The work below spans twenty years. Some of it was built inside large organizations. Some of it under the banner of this firm. All of it was led, designed, and driven by the same person you’ll work with today.
1 / 8
Health Care / Regulatory Strategy
Heart of the Solution
A medical device manufacturer had developed a promising approach to Alzheimer's treatment through a vascular pathway, but it didn't fit the prevailing research framework. After being turned down through the traditional regulatory process, they needed new channels, new allies, and a strategy that matched the strength of their science.
Approach
The science was compelling, but the traditional regulatory path wasn't built for this kind of innovation. Instead of continuing down the same channels, we built a campaign that changed the terms of the conversation. A sponsored editorial series in The Washington Post established scientific credibility with the audiences that mattered. A major Axios event put the research directly in front of senior policymakers and healthcare leaders. Targeted digital advertising reached key decision-makers across Capitol Hill and the broader health policy community. A national poll reframed the treatment as low-risk and high-potential. And when the domestic path stalled, we identified European approval as a strategic alternative, assembling a clinical trial advisory team to pursue it.
Scope
Regulatory strategy development. Multi-channel education campaign: paid media, earned media, event production. National opinion research. Clinical trial team assembly and advisory. Congressional and agency outreach. European regulatory pathway development. Targeted outreach to 2,500 healthcare leaders, congressional staff, and policymakers. Narrative monitoring and conversation analysis.
6.4M+
Impressions across Washington Post editorial series
2x
Axios event engagement vs. their public event average
25x
Earned media pickup over previous company efforts
Result
European approval secured. The product is now marketing internationally. A campaign that started as a domestic regulatory problem built enough scientific credibility and political visibility to open an entirely new market, and positioned the company to reopen the domestic conversation from a position of strength.
Health Care / Reputation
GoBoldly
The pharmaceutical industry's board leadership commissioned a large-scale national reputation campaign. The industry's public perception had become a strategic liability, and incremental efforts weren't moving the needle. The mandate was clear: change how Americans think about this industry.
Approach
Developed a national advertising and engagement campaign built around the strongest reputational attribute of the industry: the tenacity of its researchers in the fight against disease. The creative included a flagship manifesto ad, a "Together" series pairing patients and researchers, and a science-forward series showcasing cutting-edge research. Complemented the advertising with earned media, major event partnerships, and hands-on community engagement so the campaign existed in people's lives, not just on their screens.
Scope
National television, digital, and print advertising. Multi-year engagement spanning creative development, media strategy, earned media, event partnerships with major media outlets and nonprofits, and ongoing campaign management and optimization. Served as the creative engine from inception, eventually elevated to lead the entire marketing operation for five years.
Result
Moved reputation metrics with key audiences at launch and sustained momentum through multiple creative phases across five years. The campaign proved that the most powerful reputational story the industry could tell wasn't about policy. It was about the perseverance of its scientists and patients and the science that perseverance generates.
Corporate / Brand Crisis
Restoring an American Brand
A national consumer brand found itself at the center of a political and cultural firestorm after a media inflection point gave political activists and an activist investor the opening to pounce. The situation was moving faster than the company's existing response infrastructure could handle.
Approach
Brought in during the early days of the crisis to provide intelligence-driven counsel to the executive team. Developed a containment strategy for the activist campaigns and a narrative counter-offensive rooted in the brand's heritage and legacy. As the situation evolved, designed and executed a targeted influencer and earned media campaign to reach the specific audiences driving the boycott. Identified and facilitated a resolution pathway that resulted in a high-profile public endorsement, then ensured that endorsement reached the audiences where it would have the most impact.
Scope
Crisis intelligence and narrative strategy. Real-time social media monitoring and analysis. Direct strategic counsel to the executive team. Heritage-based messaging development. Targeted influencer activation. Earned media placement in audience-specific outlets.
100%+
Stock price recovery during engagement
18.9M+
Essential consumers reached
Result
Stock price recovered from a significant decline to above pre-crisis levels during the engagement. The boycott narrative lost momentum through targeted earned media and influencer activation. The strategy repositioned the brand around its own heritage rather than defensive posturing, creating a foundation for recovery.
Health Care / Patient Access
The Partnership for Prescription Assistance
Millions of uninsured Americans were paying full price for prescription medicines with no relief in sight. The industry needed to demonstrate that it was part of the solution, not just part of the problem. The answer wasn't a talking point. It was infrastructure that actually helped people.
The Help is Here Express bus tour brought prescription assistance directly to communities across all 50 states. Photo: The Times-Union
Approach
Created a national clearinghouse connecting uninsured patients with every brand-name manufacturer's patient assistance program. Built the technology platform from scratch, organized the pharmaceutical companies into a coordinated working group, and launched in all 50 states with a branded bus tour, earned media strategy, and partnerships with local and national organizations. Served as the primary spokesperson, personally leading press events in 45 states in the first year.
Scope
National campaign. 50-state media operation including press conferences, television appearances, and editorial boards. Multi-year engagement spanning concept development, technology build, stakeholder coordination, earned media, and ongoing program management. The program evolved through multiple iterations and continues to operate today as AmericanMedicines.org.
20M+
Patients connected with assistance
45+
State launches led personally
20+
Years and still running
Result
More than 20 million people gained access to medicines they otherwise couldn't afford. The program still operates today as AmericanMedicines.org. Identified by PR Week as one of the most innovative and effective communications campaigns of the 21st century. Gave the industry credibility and a seat at the table in the national health care debate.
Health Care / Narrative Strategy
Let's Talk About Cost
For over a decade, the pharmaceutical industry had been told to stay away from the drug pricing conversation publicly. When the board said "go," the campaign had to reframe a deeply entrenched national narrative and shift accountability to a part of the supply chain that most Americans had never heard of.
Approach
Reframed the national conversation from the price of medicines to the cost patients actually pay by exposing the role of pharmacy benefit managers in the supply chain. Opened with a Socratic print ad: "Insurers don't pay full price for medicine, so why should you?" Escalated to television, personifying the PBM as "the middleman" taking money from patients. Built a sustained earned media and content operation around the gap between gross and net pricing, PBM rebate practices, and insurer cost-sharing structures.
Scope
National advertising campaign spanning print, digital, and television. Multi-year engagement including creative strategy and development, media planning and optimization, real-time analytics tracking, and earned media coordination. Supporting studies, blog content, and legislative education materials.
Result
An entire category of supply chain organizations that had operated without public scrutiny became the primary accountability target in the national health care cost conversation. The campaign reframed the debate from "price" to "cost," and the term "middleman" became the dominant frame in the PBM conversation. PBM reform went from a fringe concept to enacted federal legislation, built on a foundation of public awareness that didn't exist before this campaign.
Health Care / Legislative Defense
Defending a Treatment Pathway
A health care segment faced a wave of harmful state legislation that threatened its ability to serve patients. The legislative threats were moving simultaneously across multiple states on compressed timelines, and the existing advocacy infrastructure wasn't built for that kind of speed.
Approach
Developed the umbrella strategy for a coordinated multi-state legislative defense. Created a comprehensive message framework, mapped state legislative schedules to identify key inflection points including introduction deadlines, recesses, and vote windows. Identified procedural opportunities to slow or block harmful measures based on calendar dynamics. Drafted press materials, op-eds, stakeholder education materials, and tactical recommendations for targeted engagement.
Scope
Multi-state legislative strategy. Message framework development. Legislative calendar mapping and procedural analysis. Earned media materials including press releases, op-eds, and stakeholder communications. Tactical targeting recommendations for legislative engagement. Ongoing strategic advisory.
Result
The strategy gave the organization something it hadn't had before: a coordinated playbook for fighting on multiple fronts simultaneously. The message framework, legislative calendar mapping, and editorial materials became the foundation for the organization's state-level defense effort.
Health Care / Coalition & Advocacy
We Work for Health
The pharmaceutical industry was seen as a collection of logos and lobbying dollars, not as an employer, economic engine, and community partner. Lawmakers understood the policy arguments, but they didn't feel the local connection. The industry needed a face and a footprint in their districts.
Approach
Created a program to illustrate the local footprint of the pharmaceutical industry by building alliances with community stakeholders: local governments, clinical trial sites, suppliers, distributors, and business organizations. Ran internal employee engagement workshops at individual companies through programs like Pizza and Policy and Pancakes and Politics. Created the We Work for Health Champions program to recognize employees who went above and beyond in policy advocacy. Conducted annual surveys documenting the industry's economic and employment impact by state and congressional district.
Scope
National coalition-building and employee engagement program. Internal workshops at individual member companies. Annual economic impact research by state and congressional district. Media appearances and presentations as the program's public spokesperson. Development of the Champions recognition program.
Result
Built a lasting bridge between the industry and the communities where it operates. The original program has since evolved into multiple distinct efforts, all still active, spanning community engagement, employee advocacy, and the Champions recognition program. Created a sustainable model for localizing a national industry and giving lawmakers a reason to see it as a constituent, not just a lobby.
Health Care / Issue Advocacy
Partnership to Fight Chronic Disease
Chronic disease accounted for more than 75 cents of every dollar spent on health care, but it wasn't part of the national political conversation. With the 2008 presidential election approaching, the Partnership to Fight Chronic Disease needed to make chronic disease a consideration at the ballot box.
Approach
Contributed to a national advertising campaign for the 2008 presidential election, leading the development of the flagship television ad that put a human face on the chronic disease crisis. The ad was designed to move the issue from a policy footnote to a voting consideration by connecting the personal realities of chronic disease to the political moment. The campaign challenged candidates from both parties to make chronic disease a priority in their health care platforms.
Scope
National television advertisement for the 2008 presidential election cycle. Creative development and production. Part of a broader coalition effort involving patients, providers, business groups, and health policy experts committed to raising awareness of chronic disease as the leading driver of health care costs.
Result
Elevated chronic disease from a policy footnote to a campaign issue during the 2008 presidential cycle. Candidates across both parties were publicly challenged to address chronic disease in their health care platforms. The Partnership went on to become an internationally recognized coalition that continues to advocate for chronic disease prevention and management policy.
Swipe or use arrows to navigate